MEDS: TRxADE HEALTH, Inc. Stock

by  •  • Comments Off on MEDS: TRxADE HEALTH, Inc. Stock

SIC 5122 – Drugs, Drug Proprietaries, and Druggists' Sundries

Valuation
Market Cap ($M) 8.73
Enterprise Value ($M) 15.14
Book Value ($M) 0.54
Book Value / Share 0.39
Price / Book 16.10
NCAV ($M) -9.24
NCAV / Share -6.57
Price / NCAV -0.95

Profitability (mra)
Return on Invested Capital (ROIC) -2.33
Return on Assets (ROA) -4.42
Return on Equity (ROE) -27.24

Liquidity (mrq)
Quick Ratio 0.24
Current Ratio 0.24

Balance Sheet (mrq) ($M)
Current Assets 2.75
Assets 12.53
Liabilities 11.99
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 8.27
Operating Income -7.26
Net Income -17.84
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -2.07
Cash from Investing -0.28
Cash from Financing 1.41

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 4.99 -93.30

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-01-16 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-18 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-01 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 1,768 14,415 12.27
2024-04-25 1,600 20,276 7.89
2024-04-24 1,825 16,374 11.15
2024-04-23 5,047 898 562.03
2024-04-22 9,073 4,713 192.51

(click for more detail)

Similar Companies
BIMI – BIMI Holdings Inc. COSM – Cosmos Health Inc.


Financial data and stock pages provided by
Fintel.io